Using the stratification cut-off points as in the assessment of tumor response, we found that high levels of LAG-3 were positively correlated with unfavorable clinical parameters, such as advanced tumor stage, more cirrhosis pattern and degree of hepatic damage. The gene discussed is LAG3; the disease is neoplasm.